Teva Announces FDA Approval and Launch of Saxenda® – First Generic GLP-1 Indicated for Weight Loss
On Aug. 28, 2025, Teva Pharmaceuticals announced the U.S. Food and Drug Administration (FDA) approval and U.S. launch…
Isreal
On Aug. 28, 2025, Teva Pharmaceuticals announced the U.S. Food and Drug Administration (FDA) approval and U.S. launch…